Role of thromboelastography in evaluating other anticoagulant agents: warfarin and heparin-dihydroergotamine

Semin Thromb Hemost. 1995:21 Suppl 4:59-62. doi: 10.1055/s-0032-1313623.
No abstract available

Publication types

  • Comparative Study
  • Review

MeSH terms

  • Adult
  • Aged
  • Animals
  • Anticoagulants / administration & dosage
  • Anticoagulants / pharmacology*
  • Blood Coagulation / drug effects*
  • Clinical Trials as Topic
  • Dihydroergotamine / administration & dosage
  • Dihydroergotamine / pharmacology*
  • Drug Combinations
  • Hemorrhage / chemically induced
  • Hemorrhage / prevention & control
  • Heparin, Low-Molecular-Weight / administration & dosage
  • Heparin, Low-Molecular-Weight / pharmacology*
  • Humans
  • Middle Aged
  • Monitoring, Physiologic / methods*
  • Postoperative Complications / blood
  • Postoperative Complications / prevention & control
  • Prothrombin Time
  • Rabbits
  • Reference Standards
  • Thrombelastography*
  • Thromboembolism / blood
  • Thromboembolism / drug therapy*
  • Thromboembolism / etiology
  • Thromboembolism / prevention & control
  • Warfarin / administration & dosage
  • Warfarin / pharmacology*

Substances

  • Anticoagulants
  • Drug Combinations
  • Heparin, Low-Molecular-Weight
  • heparin-dihydergot
  • Dihydroergotamine
  • Warfarin